EchoSense develops ultrasound Doppler systems and introduced the first fully automatic signal processing and classification packages for diagnosis of various cardiac and pulmonary diseases. It develops innovative ultrasound Doppler technology to enable fast, simple, and reliable diagnosis of heart and lung diseases to improve the health of millions of people worldwide. Its diagnosis and patient monitoring technology has undergone extensive clinical trials in the United States, Europe and in Israel. Its technology is ISO-certified and has acquired CE approval for peripheral blood flow measurements. It expects to make FDA and additional CE submissions for various cardio-pulmonary diagnoses during 2019.